Hypertrophic cardiomyopathy histopathology: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com & -kfeeney@perfuse.org +kfeeney@elon.edu))
 
(8 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
{{Hypertrophic cardiomyopathy}}
{{Hypertrophic cardiomyopathy}}


'''Editors-In-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:mgibson@perfuse.org], Cafer Zorkun, M.D. [mailto:zorkun@perfuse.org], Martin S. Maron, M.D., and Barry J. Maron, M.D.
'''Editors-In-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com]


==Overview==
==Overview==
Line 8: Line 9:
==Histopathologic Abnormalities==
==Histopathologic Abnormalities==
===Myocardial Disarray===
===Myocardial Disarray===
A [[cardiomyopathy]] is any disease that primarily affects the muscle of the heart. In HCM, the normal alignment of muscle cells is disrupted (there is a swirling pattern to the arrangement of the muscle cells), a phenomenon known as [[myocardial disarray]]. HCM is believed to be due to a mutation in one of many [[gene]]s that results in a mutated myosin heavy chain, one of the components of the [[myocyte]] (the muscle cell of the heart). Histopathologically, the cardiac [[sarcomere]] is abnormal resulting in hypertrophy of the [[left ventricle]] in the absence of other disorders that could produce the condition such as [[hypertension]], [[amyloid]] or [[aortic stenosis]].
In HCM, the normal alignment of muscle cells is disrupted (there is a swirling pattern to the arrangement of the muscle cells), a phenomenon known as [[myocardial disarray]]. HCM is believed to be due to a mutation in one of many [[gene]]s that results in a mutated myosin heavy chain, one of the components of the [[myocyte]] (the muscle cell of the heart). Histopathologically, the cardiac [[sarcomere]] is abnormal resulting in hypertrophy of the [[left ventricle]] in the absence of other disorders that could produce the condition such as [[hypertension]], [[amyloid]] or [[aortic stenosis]].  The presence of [[myocardial disarray]] may be associated with abnormalities of electrical conduction in the heart (including electrical reentry loops) which thereby contributes to an increased risk of [[sudden cardiac death]].


<div align="left">
<div align="left">
Line 17: Line 18:
</gallery>
</gallery>
</div>
</div>


===Periarteriolar Fibrosis===
===Periarteriolar Fibrosis===
Compared to normal arterioles on the left, the arterioles from a patient with hyertension (middle) show moderate periarteriolar thickening and fibrosis. Shown on the right is a patient with HCM in which there is even more signficant periarteriolar thickening and fibrosis. This thickening of the wall of the intramyocardial arterioles leads to an increased wall/lumen ratio, subendocardial ischemia and impaired coronary flow reserve. Patients who subsequently died in one series had abnormal coronary flow reserve on PET scanning at baseline indicating that ischemia may play a role, at least in part, in subsequent mortality.
Compared to normal arterioles on the left, the arterioles from a patient with hyertension (middle) show moderate periarteriolar thickening and fibrosis. Shown on the right is a patient with HCM in which there is even more signficant periarteriolar thickening and fibrosis. This thickening of the wall of the intramyocardial arterioles leads to an increased wall/lumen ratio, subendocardial ischemia and impaired [[coronary flow reserve]]<ref name="pmid9842009">{{cite journal| author=Lorenzoni R, Gistri R, Cecchi F, Olivotto I, Chiriatti G, Elliott P et al.| title=Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction. | journal=Am Heart J | year= 1998 | volume= 136 | issue= 6 | pages= 972-81 | pmid=9842009 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9842009  }} </ref><ref name="pmid10097830">{{cite journal| author=Choudhury L, Elliott P, Rimoldi O, Ryan M, Lammertsma AA, Boyd H et al.| title=Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment. | journal=Basic Res Cardiol | year= 1999 | volume= 94 | issue= 1 | pages= 49-59 | pmid=10097830 | doi= | pmc= | url= }} </ref>. Patients who subsequently died in one series had abnormal coronary flow reserve on PET scanning at baseline indicating that ischemia may play a role, at least in part, in subsequent mortality.


<div align="left">
<div align="left">
Line 30: Line 30:
</div>
</div>


==Microscopic Pathological Findings==
Histopathologically, small vessels have hypertrophy of the tunica media.  Combined with increased wall tension, decreased vasodilator reserve and inadequate capillary density, there is a mismatch between blood supply and demand.  Over time, it is thought that there is repeated ischemia followed by fibrosis and eventually, dilation and systolic dysfunction (“burned out hypertrophy”).
<div align="left">
<gallery heights="175" widths="175">
Image:3380.jpg|Micro med mag H&E mid-mural myocardium with hypertrophy and interstitial fibrosis atrophy is present marked increase in interstitial fibroblastic cells
Image:3381.jpg|Micro high mag H&E myofiber hypertrophy and interstitial fibrosis with marked increase in interstitial fibroblastic cells
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:3480.jpg|Micro med mag H&E myofiber hypertrophy some atrophy interstitial fibrosis with many fibroblastic cells
Image:3481.jpg|Micro high mag H&E hypertrophied fibers with some evidence of atrophy and marked interstitial fibrosis with many fibroblastic type cells
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:3482.jpg|Micro low mag H&E shows myofiber hypertrophy and interstitial fibrosis
Image:439.jpg|Cardiomyopathy: Micro H&E low mag interventricular septum at junction of normal myofiber orientation with asymmetrical hypertrophy (an excellent example)
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:440.jpg|Cardiomyopathy: Micro H&E low mag marked myofiber disarray asymmetrical hypertrophy
Image:441.jpg|Cardiomyopathy: Micro trichrome high mag marked myofiber disarray
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:442.jpg|Cardiomyopathy: Micro H&E med mag excellent example myofiber disarray
Image:438.jpg|Cardiomyopathy: Micro H&E high mag excellent example myofiber disarray
</gallery>
</div>
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
Line 35: Line 78:
[[Category: Cardiology]]
[[Category: Cardiology]]
[[Category: Pathology]]
[[Category: Pathology]]
[[Category: Overview present]]
[[Category:Cardiomyopathy]]
[[Category: Template present]]
[[Category: Overview complete]]
[[Category: Template complete]]
[[Category: Genetic disorders]]

Latest revision as of 16:57, 1 November 2012

Hypertrophic Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypertrophic Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypertrophic cardiomyopathy histopathology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertrophic cardiomyopathy histopathology

CDC on Hypertrophic cardiomyopathy histopathology

Hypertrophic cardiomyopathy histopathology in the news

Blogs on Hypertrophic cardiomyopathy histopathology

Directions to Hospitals Treating Hypertrophic cardiomyopathy

Risk calculators and risk factors for Hypertrophic cardiomyopathy histopathology

Editors-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

On histopathologic examination, hypertrophic cardiomyopathy is characterized by both myocardial disarray and by periarteriolar fibrosis. Myocardial disarray can be associated with aberrant impulse conduction and arrhythmias, and periarteriolar fibrosis can be associated with myocardial ischemia.

Histopathologic Abnormalities

Myocardial Disarray

In HCM, the normal alignment of muscle cells is disrupted (there is a swirling pattern to the arrangement of the muscle cells), a phenomenon known as myocardial disarray. HCM is believed to be due to a mutation in one of many genes that results in a mutated myosin heavy chain, one of the components of the myocyte (the muscle cell of the heart). Histopathologically, the cardiac sarcomere is abnormal resulting in hypertrophy of the left ventricle in the absence of other disorders that could produce the condition such as hypertension, amyloid or aortic stenosis. The presence of myocardial disarray may be associated with abnormalities of electrical conduction in the heart (including electrical reentry loops) which thereby contributes to an increased risk of sudden cardiac death.

Periarteriolar Fibrosis

Compared to normal arterioles on the left, the arterioles from a patient with hyertension (middle) show moderate periarteriolar thickening and fibrosis. Shown on the right is a patient with HCM in which there is even more signficant periarteriolar thickening and fibrosis. This thickening of the wall of the intramyocardial arterioles leads to an increased wall/lumen ratio, subendocardial ischemia and impaired coronary flow reserve[1][2]. Patients who subsequently died in one series had abnormal coronary flow reserve on PET scanning at baseline indicating that ischemia may play a role, at least in part, in subsequent mortality.


Microscopic Pathological Findings

Histopathologically, small vessels have hypertrophy of the tunica media. Combined with increased wall tension, decreased vasodilator reserve and inadequate capillary density, there is a mismatch between blood supply and demand. Over time, it is thought that there is repeated ischemia followed by fibrosis and eventually, dilation and systolic dysfunction (“burned out hypertrophy”).





References

  1. Lorenzoni R, Gistri R, Cecchi F, Olivotto I, Chiriatti G, Elliott P; et al. (1998). "Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction". Am Heart J. 136 (6): 972–81. PMID 9842009.
  2. Choudhury L, Elliott P, Rimoldi O, Ryan M, Lammertsma AA, Boyd H; et al. (1999). "Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment". Basic Res Cardiol. 94 (1): 49–59. PMID 10097830.